Free Trial

Calithera Biosciences (CALA) Competitors

Calithera Biosciences logo
$0.0006 0.00 (0.00%)
As of 05/21/2025

CALA vs. EVLO, GNCAQ, GNCA, ARDS, STAB, AMPE, CMRA, EFTR, CLVR, and ONCSQ

Should you be buying Calithera Biosciences stock or one of its competitors? The main competitors of Calithera Biosciences include Evelo Biosciences (EVLO), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Ampio Pharmaceuticals (AMPE), Comera Life Sciences (CMRA), eFFECTOR Therapeutics (EFTR), Clever Leaves (CLVR), and OncoSec Medical (ONCSQ). These companies are all part of the "pharmaceutical products" industry.

Calithera Biosciences vs.

Evelo Biosciences (NASDAQ:EVLO) and Calithera Biosciences (NASDAQ:CALA) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, media sentiment, analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.

Calithera Biosciences received 171 more outperform votes than Evelo Biosciences when rated by MarketBeat users. However, 60.50% of users gave Evelo Biosciences an outperform vote while only 55.09% of users gave Calithera Biosciences an outperform vote.

CompanyUnderperformOutperform
Evelo BiosciencesOutperform Votes
170
60.50%
Underperform Votes
111
39.50%
Calithera BiosciencesOutperform Votes
341
55.09%
Underperform Votes
278
44.91%

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evelo BiosciencesN/AN/A-$114.53MN/AN/A
Calithera BiosciencesN/AN/A-$39.65MN/AN/A

In the previous week, Calithera Biosciences had 1 more articles in the media than Evelo Biosciences. MarketBeat recorded 1 mentions for Calithera Biosciences and 0 mentions for Evelo Biosciences. Evelo Biosciences' average media sentiment score of 0.32 beat Calithera Biosciences' score of 0.00 indicating that Evelo Biosciences is being referred to more favorably in the media.

Company Overall Sentiment
Evelo Biosciences Neutral
Calithera Biosciences Neutral

0.3% of Evelo Biosciences shares are owned by institutional investors. 1.0% of Evelo Biosciences shares are owned by insiders. Comparatively, 6.6% of Calithera Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
Evelo BiosciencesN/A N/A N/A
Calithera Biosciences N/A N/A N/A

Evelo Biosciences has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Comparatively, Calithera Biosciences has a beta of -2.38, indicating that its stock price is 338% less volatile than the S&P 500.

Summary

Evelo Biosciences and Calithera Biosciences tied by winning 4 of the 8 factors compared between the two stocks.

Get Calithera Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CALA and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CALA vs. The Competition

MetricCalithera BiosciencesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$3,000.00$6.48B$5.33B$8.39B
Dividend YieldN/A2.64%5.21%4.11%
P/E RatioN/A9.0626.7119.71
Price / SalesN/A251.50386.13120.55
Price / CashN/A65.8538.2534.62
Price / BookN/A6.456.774.50
Net Income-$39.65M$143.98M$3.23B$248.22M
7 Day PerformanceN/A2.41%1.80%0.56%
1 Month PerformanceN/A4.56%11.10%13.17%
1 Year PerformanceN/A-2.67%17.11%7.30%

Calithera Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CALA
Calithera Biosciences
N/A$0.00
flat
N/A-97.0%$3,000.00N/A0.0060Analyst Forecast
EVLO
Evelo Biosciences
N/A$0.00
+66.7%
N/AN/A$9,000.00N/A0.00120Gap Up
High Trading Volume
GNCAQ
Genocea Biosciences
N/AN/AN/AN/A$6,000.00N/A0.0070
GNCA
Genocea Biosciences
N/AN/AN/AN/A$6,000.00$1.91M0.0070Analyst Forecast
ARDS
Aridis Pharmaceuticals
N/A$0.00
flat
N/A-99.8%$5,000.00$3.09M0.0030
STAB
Statera Biopharma
N/A$0.00
flat
N/A-85.7%$5,000.00N/A0.0020
AMPE
Ampio Pharmaceuticals
N/A$0.00
+3.3%
N/A-98.8%$4,000.00N/A0.0020Gap Up
CMRA
Comera Life Sciences
N/AN/AN/AN/A$3,000.00$1.00M0.002
EFTR
eFFECTOR Therapeutics
N/A$0.00
flat
N/A-100.0%$3,000.00$3.55M0.0010
CLVR
Clever Leaves
N/A$0.00
flat
N/A-100.0%$1,000.00$17.42M0.00560
ONCSQ
OncoSec Medical
N/AN/AN/AN/A$1,000.00N/A0.0040

Related Companies and Tools


This page (NASDAQ:CALA) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners